News tagged with molecular pathology
Are human genes patentable?
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics
Apr 11, 2013 |
4.3 / 5 (6) |
16
|
How the brain forms categories
Neurobiologists at the Research Institute of Molecular Pathology (IMP) in Vienna investigated how the brain is able to group external stimuli into stable categories. They found the answer in the discrete ...
Neuroscience
Oct 20, 2012 |
3.8 / 5 (5) |
1
U.S. Supreme Court petitioned to review AMP, et al. lawsuit on gene patents
The American Civil Liberties Union and the Public Patent Foundation have petitioned the U.S. Supreme Court to hear Association for Molecular Pathology v. U.S. Patent and Trademark Office, a case that challenges the validity ...
Other
Dec 15, 2011 |
5 / 5 (2) |
0
AMP presented testimony to the Patent and Trademark Office requesting moratorium on human gene patenting
Today, the Association for Molecular Pathology (AMP) asked the U.S. Patent and Trademark Office (USPTO) to place a moratorium on the issuing of patents on human genes during testimony presented at an Agency hearing on genetic ...
Genetics
Feb 16, 2012 |
5 / 5 (2) |
0
A key gene for brain development
(Medical Xpress)—Neurobiologists at the Research institute of Molecular Pathology (IMP) in Vienna have discovered one of the key genes required to make a brain. Mutations in this gene, called TUBB5, cause ...
Genetics
Dec 14, 2012 |
5 / 5 (2) |
0
|
Researchers report new understanding of role of telomeres in tumor growth
The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal of ...
Cancer
Sep 01, 2011 |
5 / 5 (1) |
0
Proposed NIH genetic testing registry lacks clarity, understates costs
The Association for Molecular Pathology (AMP) submitted comments to the National Institutes of Health (NIH), in which the Association voiced concerns about the proposed Genetic Testing Registry (GTR) as currently designed, ...
Genetics
Oct 28, 2011 |
5 / 5 (1) |
0
Insulin therapy may help repair atherosclerotic lesions in diabetic patients
New research reveals that insulin applied in therapeutic doses selectively stimulates the formation of new elastic fibers in cultures of human aortic smooth muscle cells. These results advance the understanding of the molecular ...
Diseases, Conditions, Syndromes
Jan 09, 2012 |
5 / 5 (1) |
0
Aurora-A hinders tumor-suppressor to allow chemotherapy resistance
A protein abundantly found in treatment-resistant cancers holds an important tumor-suppressor out of the cell nucleus, where it would normally detect DNA damage and force defective cells to kill themselves, a team of scientists ...
Cancer
Feb 27, 2012 |
5 / 5 (1) |
0
|
Genome-scale study identifies hundreds of potential drug targets for Huntington's disease
Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) ...
Genetics
Nov 29, 2012 |
5 / 5 (1) |
0
|
Inherited retinal disease research may lead to treatment
Inherited retinal disease is a major cause of vision impairment in early life - and a researcher at The University of Western Australia hopes a study in which he was involved will contribute towards the development ...
Medical research
Jan 08, 2013 |
5 / 5 (1) |
0
Enzyme replacement therapy shows promising results in X-linked myotubular myopathy
A collaborative research team including a Medical College of Wisconsin (MCW) pediatric neuropathologist successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy ...
Genetics
Jan 22, 2013 |
5 / 5 (1) |
0
Protein central to cancer stem cell formation provides new potential target
Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.
Cancer
Feb 13, 2013 |
5 / 5 (1) |
0
Rejected Alzheimer's drug shows new potential
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped ...
Psychology & Psychiatry
Jul 31, 2012 |
4 / 5 (1) |
1
|
Researchers define how a gene mutated in Parkinson's disease may normally function to ensure neuronal health
(Medical Xpress)—Cell biologists studying Parkinson's disease are training their sights on mitochondria, the energy source of the cell, whose activity in neurons appears to go awry in this devastating neurodegenerative ...
Medical research
Mar 22, 2013 |
4 / 5 (1) |
0
